| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A randomised phase II study of chemoradiotherapy with or without nimotuzumab in locally advanced oesophageal cancer: NICE trial
|
de Castro Junior, Gilberto
|
|
2018
|
88 |
C |
p. 21-30
|
artikel
|
| 2 |
Corrigendum to “Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer” [Eur J Cancer 40 (18) (2004) 2717–2725]
|
Martin, Tracey A.
|
|
2018
|
88 |
C |
p. 115-116
|
artikel
|
| 3 |
EJC's biennial report on metastatic soft tissue sarcoma: State of the art and future perspectives
|
Vos, Melissa
|
|
2018
|
88 |
C |
p. 87-91
|
artikel
|
| 4 |
Farewell to monomodality treatment in patients with WHO lower grade glioma?
|
Le Rhun, Emilie
|
|
2018
|
88 |
C |
p. 109-114
|
artikel
|
| 5 |
HER2 copy number of circulating tumour DNA functions as a biomarker to predict and monitor trastuzumab efficacy in advanced gastric cancer
|
Wang, Haixing
|
|
2018
|
88 |
C |
p. 92-100
|
artikel
|
| 6 |
Mammographic density and breast cancer risk in breast screening assessment cases and women with a family history of breast cancer
|
Duffy, Stephen W.
|
|
2018
|
88 |
C |
p. 48-56
|
artikel
|
| 7 |
No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands
|
Timmermans, M.
|
|
2018
|
88 |
C |
p. 31-37
|
artikel
|
| 8 |
Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria
|
Tazdait, M.
|
|
2018
|
88 |
C |
p. 38-47
|
artikel
|
| 9 |
PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanoma
|
Schaper-Gerhardt, Katrin
|
|
2018
|
88 |
C |
p. 67-76
|
artikel
|
| 10 |
Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients
|
Valpione, S.
|
|
2018
|
88 |
C |
p. 1-9
|
artikel
|
| 11 |
Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study
|
Musolino, A.
|
|
2018
|
88 |
C |
p. 10-20
|
artikel
|
| 12 |
Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study
|
Gaspar, Nathalie
|
|
2018
|
88 |
C |
p. 57-66
|
artikel
|
| 13 |
Reviewers 2017
|
|
|
2018
|
88 |
C |
p. 117
|
artikel
|
| 14 |
Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer—central evaluation of FIRE-3
|
Modest, D.P.
|
|
2018
|
88 |
C |
p. 77-86
|
artikel
|
| 15 |
The use of palliative medications before death from prostate cancer: Swedish population-based study with a comparative overview of European data
|
Lycken, Magdalena
|
|
2018
|
88 |
C |
p. 101-108
|
artikel
|
Tijdschrift beschrijving